Industry Sessions
Thursday, 5 September 2019
ENDOCANNABINOID SIGNALLING AND ITS INVOLVEMENT IN PAIN
Exhibition Area
Open Forum organised by:
|
10:00 – 10:20 |
ENDOCANNABINOID SIGNALLING AND ITS INVOLVEMENT IN PAIN Mauro Maccarrone (Italy) |
FROM THEORY TO REAL WORLD EVIDENCE: WHAT CAN WE LEARN TO IMPROVE THE TREATMENT IN SEVERE CHRONIC PAIN? A NEW VIEW ON TAPENTADOL IN SEVERE CHRONIC PAIN
Auditorium 1A
Chair: Ralf Baron (Germany)
Symposium is organised and supported by:
|
12:15 – 12:20 |
CHAIR’S WELCOME Ralf Baron (Germany) |
|
12:20 – 12:35 |
DOES THE MECHANISM OF ACTION MATTER IN TREATMENT OF PAIN? Stephan Schug (Australia) |
|
12:35 – 12:50 |
FROM MECHANISM OF ACTION TO CLINICAL BENEFIT: ATYPICAL OPIOID = TYPICAL OUTCOMES? Ralf Baron (Germany) |
|
12:50 – 13:10 |
TREATING PAIN WITH THE RIGHT ARMAMENTARIUM EARLY: DOES IT MAKE A DIFFERENCE? Michael Überall (Germany) |
|
13:10 – 13:35 |
TRANSLATING TRIAL AND RWE LEARNINGS TO CLINICAL PRACTICE: HOW TO EFFECTIVELY UTILIZE TAPENTADOL Flaminia Coluzzi (Italy) |
|
13:35 – 13:45 |
Q&A AND CLOSE Ralf Baron (Germany) |
COMMUNICATING PAIN SCIENCE, WITH PATIENTS AND FOR PATIENTS
Room 4C
Chair: Morten Hoegh (Denmark)
Symposium is organised by the European Pain Federation EFIC® with the kind support of:
|
12:15 – 12:20 |
WELCOME AND INTRODUCTION Morten Hoegh (Denmark) |
|
12:20 – 12:30 |
CO-PRODUCTION: THE UNIQUE VALUE OF EDUCATIONAL MATERIAL FOR PEOPLE WITH CHRONIC PAIN DEVELOPED JOINTLY BY HEALTHCARE PROFESSIONALS AND PATIENT REPRESENTATIVES Neil Betteridge (UK) |
|
12:30 – 12:40 |
PATIENTS AND HEALTHCARE PROFESSIONAL COOPERATION TO FOSTER PATIENT EDUCATION – A NATIONAL PERSPECTIVE Marja Kinnunen (Finland) |
|
12:50 – 13:25 |
Q&A SESSION: TAKING STOCK OF EVIDENCE TO IMPROVE COOPERATION |
|
13:25 – 13:30 |
CONCLUSIONS Morten Hoegh (Denmark) |
NOT ‘JUST CONSTIPATION’: ADDRESSING OPIOIDS’ NEGLECTED SIDE EFFECT
Hall 1B
Chair: Asbjørn Drewes (Denmark)
Symposium is organised and supported by:
|
12:15 – 12:20 |
WELCOME INTRODUCTION Asbjørn Drewes (Denmark) |
|
12:20 – 12:30 |
WHAT WE KNOW ABOUT OIC Asbjørn Drewes (Denmark) |
|
12:30 – 12:45 |
PERSPECTIVES ON OIC FROM THE PATIENT AND PHYSICIAN Mike Bennett (United Kingdom) |
|
12:45 – 13:05 |
EUROPEAN TREATMENT GUIDELINES: WHAT’S NEW? Bart Morlion (Belgium) |
|
13:05 – 13:25 |
THE ROLE OF PAMORAS IN OIC Tony O’Brien (Ireland) |
|
13:25 – 13:40 |
Q&A SESSION All faculty |
|
13:40 – 13:45 |
CLOSE Asbjørn Drewes (Denmark) |
PREPARING FOR THE ERA OF TARGETED THERAPY IN CHRONIC LOW BACK PAIN: A PATIENT-CENTRIC APPROACH
Auditorium 3A
Chair: Thomas R. Tölle (Germany)
Symposium is organized by Medscape Education Global and Supported by an independent educational sponsorship from Pfizer, Inc and Eli Lilly Company.
|
12:15 – 12:45 |
TREATMENT STRATEGIES FOR CHRONIC LOW BACK PAIN – A CASE JOURNEY Thomas R. Tölle (Germany) |
|
12:45 – 13:30 |
PANEL DISCUSSION – CURRENT AND EMERGING THERAPIES FOR CHRONIC LOW BACK PAIN Thomas R. Tölle (Germany), Elon Eisenberg (Israel), Per Hansson (Sweden), Serge Perrot (France) |
|
13:30 – 13:45 |
CLOSING SESSION – KEY MESSAGES AND AUDIENCE Q&A Thomas R. Tölle (Germany), Elon Eisenberg (Israel), Per Hansson (Sweden), Serge Perrot (France) |
THE USE OF TOPICAL AND SYSTEMIC ANALGESICS TO TREAT BODY PAIN
Room 3F
Chair: Sarah Jarvis (United Kingdom)
Symposium is organised and supported by:
|
18:15 – 18:20 |
WELCOME AND INTRODUCTIONS Sarah Jarvis (United Kingdom) |
|
18:20 – 18:40 |
IMPACT OF MUSCULOSKELETAL PAIN AND THE ROLE OF EARLY SELF-CARE IN PREVENTING ESCALATION TO CHRONICITY Sarah Jarvis (United Kingdom) |
|
18:40 – 19:05 |
PRODUCT CHOICES FOR THE TREATMENT OF MUSCULOSKELETAL PAIN Angel Lanas (Spain) |
|
19:05 – 19:30 |
THE ROLE OF PAIN MANAGEMENT AND LIFESTYLE CHANGES IN MANAGING MUSCULOSKELETAL PAIN Hans-Georg Predel (Germany) |
|
19:30 – 19:45 |
Q&A Sarah Jarvis (United Kingdom) |
DECODING MIXED PAIN – A BLUEPRINT TO UNDERSTAND A POORLY DEFINED CONDITION
Room 4F
Chair: Rainer Freynhagen (Germany)
Symposium is organised and supported by:
|
18:15 – 18:20 |
OPENING AND WELCOME Rainer Freynhagen (Germany) |
|
18:20 – 18:45 |
WHAT THE HECK IS MIXED PAIN? Rainer Freynhagen (Germany) |
|
18:45 – 19:15 |
DISTINGUISHING MIXED PAIN IN CLINICAL PRACTICE IN THE ABSENCE OF SPECIFIC TESTS Stephan A Schug (Australia) |
|
19:15 – 19:45 |
MIXED PAIN TREATMENT TODAY – PREDICTABLY UNPREDICTABLE? Bart Morlion (Belgium) |
Feeling the Pain - perspectives on chronic pain from patients, clinicians and employers
Room 2H
This symposium is funded and organized by Pfizer and Lilly in partnership with European Pain Federation EFIC and Pain Alliance Europe.
| 18:15-18:30 |
CAN WE TAKE THE PAIN OUT OF PAIN MANAGEMENT? Bart Morlion (Belgium) |
|
18:30-18:45 |
FEELING THE PAIN IS IN EVERYDAY LIFE Brona Fullen (Ireland) |
|
18:45-19:00 |
REDUCING THE STRAIN – SUPPORTING PEOPLE TO REMAIN PRODUCTIVE AT WORK David Roomes (United Kingdom) |
|
19:00-19:15 |
EXPLORING THE PAIN IN CLINICAL MANAGEMENT AND PATIENT PRIORITIES Serge Perrot (France) |
|
19:15-19:40 |
PANEL DISCUSSION – HOW CAN WE WORK TOGETHER FOR MUTUAL GAINS IN CHRONIC PAIN MANAGEMENT Faculty facilitated by Brona Fullen (Ireland) |
|
19:40-19:45 |
CLOSING MESSAGE Serge Perrot (France) |
Friday, 6 September 2019
ENDOCANNABINOID SIGNALLING AND ITS INVOLVEMENT IN PAIN
Exhibition Area
Open Forum organised by:
|
10:00 – 10:20 |
ENDOCANNABINOID SIGNALLING AND ITS INVOLVEMENT IN PAIN Mauro Maccarrone (Italy) |
BENEATH THE SKIN: ADVANCES IN PERIPHERAL NEUROPATHIC PAIN MANAGEMENT
Auditorium 1A
Chair: Burkhard Gustorff (Austria)
Symposium is organised and supported by:
|
12:15-12:20 |
CHAIR’S WELCOME Burkhard Gustorff (Austria) |
|
12:20-12:45 |
PERSISTENT PERIPHERAL NEUROPATHIC PAIN RELIEF FOLLOWING QUTENZA TREATMENT: LOOKING UNDER THE SURFACE Praveen Anand (United Kingdom) |
|
12:45-13:10 |
THE PACE STUDY: NEW INSIGHTS – NEW HYPOTHESIS Nathaniel Katz (USA) |
|
13:10-13:35 |
PERIPHERAL NEUROPATHIC PAIN: WHAT MATTERS BEYOND PAIN INTENSITY? Serge Perrot (France) |
|
13:35-13:45 |
Q&A AND CLOSE |
THE EVOLVING ROLE THAT MEDICAL CANNABIS PLAYS IN PAIN MANAGEMENT: THE SPECIALIST’S PERSPECTIVE
Hall 1B
Chair: Paola Cubillos (Columbia)
Symposium is organised and supported by
|
12:15 – 12:45 |
THE LATEST UPDATES ON CANNABINOIDS, THE ENDOCANNABINOID SYSTEM BIOLOGY, & THE PAIN PATHWAY Konrad F. Cimander (Germany) |
|
12:45 – 13:15 |
A REVIEW OF THE EFFICACY AND SAFETY OF MEDICAL CANNABIS IN PAIN Paola Cubillos (Columbia) |
|
13:15 – 13:45 |
GUIDELINES AND RESEARCH: WHERE WE ARE TODAY AND WHERE ARE WE GOING Arun Bhaskar (United Kingdom) |
PAIN RELIEF, OPIOIDS AND CONSTIPATION: UNDERSTANDING A SIGNIFICANT AND COMMON PROBLEM
Auditorium 3A
Chair: Bart Morlion (Belgium)
Symposium is organised and supported by:
|
12:15 – 12:25 |
INTRODUCTION: RESPONSIBLE USE OF OPIOIDS FOR PAIN MANAGEMENT Bart Morlion (Belgium) |
|
12:25 – 12:45 |
THE IMPORTANCE OF A HOLISTIC APPROACH FOR OPTIMAL PAIN MANAGEMENT IN SUPPORTIVE CARE César Margarit (Spain) |
|
12:45 – 13:05 |
INSIGHTS FROM BREAKTHROUGH CANCER PAIN AND OPIOID-INDUCED CONSTIPATION IN CLINICAL PRACTICE Andrew Davies (United Kingdom) |
|
13:05 – 13:25 |
BREAKTHROUGH CANCER PAIN AND OPIOID-INDUCED CONSTIPATION IN THE REAL WORLD: INTERACTIVE CLINICAL CASES Mario di Palma (France) |
|
13:25 – 13:40 |
Q&A All faculty |
|
13:40 – 13:45 |
SUMMARY AND CLOSE Bart Morlion (Belgium) |
TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION (TENS): TOUCHPOINTS TO INSPIRE PATIENT-DIRECTED CONTROL IN CHRONIC PAIN
Room 3F
Chair: Rolf-Detlef Treede (Germany)
Symposium is organised and supported by:
|
12:15 – 12:20 |
WELCOME AND INTRODUCTION Rolf-Detlef Treede (Germany) |
|
12:20 – 12:45 |
TENS IN CHRONIC PAIN: A FRESH LOOK AT THE EVIDENCE Mark Johnson (United Kingdom) |
|
12:45 – 13:00 |
TENS: VISUALISING THE MECHANISM OF ACTION FOR RELIEF OF CHRONIC PAIN Dawn Chesher (GlaxoSmithKline) |
|
13:00 – 13:20 |
EVOLVING TENS: HOW ARE NOVEL INNOVATIONS IMPROVING PATIENT CARE? Christian Maihöfner (Germany) |
|
13:20 – 13:40 |
TREATMENTS FOR CHRONIC PAIN: WHAT DO PATIENTS WANT? (PANEL DISCUSSION) All faculty |
|
13:40 – 13:45 |
SUMMARY AND CLOSE Rolf-Detlef Treede (Germany) |